The Oligonucleotide Therapeutics Society Gifts the 2021 Virtual Convention

Press Commence

up to this level: Sep 4, 2021 08: 00 PDT

September 4, 2021 ( –

The Oligo Meeting is purposefully designed to bring other folks together to share unbelievable trends within the sphere of oligonucleotide therapeutics. While silent unable to return together in particular person, OTS management believes within the vitality of sharing science and the devoted organizing committee has deliberate a expert, outstanding, and thrilling match whereby attendees will join leading scientists from round the arena.

Final three hundred and sixty five days’s virtual assembly used to be extraordinarily successful, and this three hundred and sixty five days’s virtual convention has been in moderation deliberate to be even extra seamlessly enticing and productive. All of the parts of the in-particular person annual assembly will seemingly be included: sessions, short talks, posters, exhibitors, and networking, which will seemingly be accessed via one on-line platform. Recorded talks and posters is also considered on-seek recordsdata from via December 31, 2021, for all registered delegates. A fun and interactive networking tool will seemingly be on hand within the course of your entire four days of the assembly, 24 hours a day.

Session issues feature Nucleic Acid Chemistry, Rare Illnesses, 20th Anniversary of Mammalian RNAi, Supply, Genome and RNA Editing, Bob Letsinger, PhD – 100 Years of Historical previous, and the Awards Presentation. The closing sessions include two Oligonucleotide Preclinical sessions and develop with the highly anticipated Scientific Reports session.

This three hundred and sixty five days’s featured match speakers include a out of the ordinary lineup of leading consultants protecting a mountainous differ of oligonucleotide-based disciplines.

Stanley T. Crooke, MD, PhD, Founder and CEO of n-Lorem Basis and founder, ragged CEO, and Chairman of the Board at Ionis led the scientific pattern of a fresh platform for drug discovery: antisense technology. He engineered the creation of one of many largest, extra evolved pattern pipelines within the biotechnology industry.

John Maraganore, PhD, is the CEO and Director of Alnylam Prescribed tablets, which has led the translation of RNA interference from Nobel Prize-profitable discovery into an progressive, fully fresh class of medicines.

Marie Wikström Lindholm, PhD, SVP and Head of Molecular Blueprint at Silence Therapeutics built and leads a expert group at Silence focusing on appealing-tuning the plan of their proprietary GalNAc-conjugated siRNA technology and exploring siRNA provide out of doors the hepatocyte.

Craig Mello, PhD, is a joint winner of the 2006 Nobel Prize in Physiology or Medicines for the discovery of RNA interference. He has been titillating on several RNAi-based biotechnology firms and no longer too long ago co-based Atalanta Therapeutics.

Kelvin K. Ogilvie, PhD, a number one educated on biotechnology, bioorganic chemistry, and genetic engineering, invented the drug Ganciclovir and developed a overall design for the chemical synthesis of great RNA molecules, which is silent the premise for RNA synthesis worldwide.

Laura Sepp-Lorenzino, PhD oversees all drug learn across in vivo and engineered cell therapy areas as Chief Scientific Officer at Intellia Therapeutics, Inc., a company creating healing genome editing therapies to positively rework the lives of folk with genetic diseases.

These are beautiful about a of the many consultants that attendees will hear from as they direct attention-grabbing and reducing-edge issues. Final three hundred and sixty five days’s virtual convention acquired rave opinions from participants and this three hundred and sixty five days’s virtual assembly is anticipated to be even extra spectacular.

These wishing to lend a hand can register here.

Media Contact:

Geri Beaty

Phone: (619)795-9458

Email: [email protected]

Supply: Oligonucleotide Therapeutics Society

Related Articles

Back to top button
%d bloggers like this: